Rongchang Bio

Activity by year

2020202120222023202420252026

New facility

Feb 19, 2020NEW FACILITYYantai, Shandong, China$710.0Mops 2023
Rongchang Bio starts construction of biopharmaceutical R&D and industrialization project in Yantai
Rongchang Bio held a groundbreaking ceremony for its biopharmaceutical R&D and industrialization project in Yantai, Shandong, with an investment of 5 billion yuan, to be completed by 2023, producing 6 million units of Telitacicept and 3 million units of Disitamab vedotin annually.
Rongchang Bio #Medical Devices jiaodong.net

Site	Largest	Latest
Yantai, China	$710.0M	2020-02-19

Loading…